🇺🇸 FDA
Pipeline program

FVH1 - a DNA-based influenza vaccine

B2011:131

Phase 1 mab completed

Quick answer

FVH1 - a DNA-based influenza vaccine for Influenza, Human is a Phase 1 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Influenza, Human
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials